Nanobiotix S.A. (LON:0QAV)
London · Delayed Price · Currency is GBP · Price in EUR 18.84
+0.56 (3.06%)
Jan 15, 2026, 5:03 PM GMT
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of 770.93 million as of January 15, 2026. Its market cap has increased by 555.33% in one year.
Market Cap
770.93M
Enterprise Value
790.37M
Revenue
8.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.84
Market Cap Chart
Since October 29, 2012, Nanobiotix's market cap has increased from 53.24M to 770.93M, an increase of 1,348.05%. That is a compound annual growth rate of 22.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 770.93M | -6.33% |
| Dec 31, 2025 | 822.99M | 594.23% |
| Dec 31, 2024 | 118.55M | -56.33% |
| Dec 29, 2023 | 271.46M | 142.59% |
| Dec 30, 2022 | 111.90M | -47.64% |
| Dec 31, 2021 | 213.73M | -49.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.25B |
| GSK plc | 75.31B |
| Haleon | 32.26B |
| Smith & Nephew | 10.22B |
| Convatec Group | 4.60B |
| Hikma Pharmaceuticals | 3.41B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.68B |